1982-1988 | Study of Biology, Julius Maximilian University, Würzburg |
1988-1991 |
PhD thesis, Institute for Genetics and Department for Tumor Biology, Department of Neurology, Julius Maximilian University, Würzburg (Supervisors: Prof. Dr. E. Buchner, Prof. Dr. U. Bogdahn) Biochemical Characterisation and Cloning of a Tumor Growth Regulating Peptide (MIA) |
1991 | PhD degree (Dr. rer. nat.) in Neurobiology |
1991-1992 | Post Doctoral Researcher, Department of Neurology, University Würzburg |
1992-1994 | Post Doctoral Fellow, Salk Institute for Biological Studies, San Diego, USA (Prof. Dr. D. Schubert Group) |
1994-1996 | Head of the Steroidpharmacology Group, Max Planck Institute of Psychiatry, Munich (Director: Prof. Dr. Dr. F. Holsboer) |
1997-2002 | Head (C3) of an Independent Max Planck Society Research Group, Max Planck Institute of Psychiatry, Munich |
1999 |
Habilitation, Medical Faculty, Ludwig Maximilians University, Munich Oxidative Stress, Neurodegeneration und Neuroprotection in Cellular Model Systems |
2001 | Appointment as Full Professor (C4) for Pathobiochemistry, Johannes Gutenberg University, Mainz |
since 2002 | Full Professor (C4) for Pathobiochemistry and Chair of the Department of Pathobiochemistry at the Institute for Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University, Mainz |
2003-2008 | Executive Director of the Institute for Physiological Chemistry and Pathobiochemistry |
2005-2010 | Chairman of the Interdisciplinary Research Center for Neurosciences (IFZN/IFSN) of the Johannes Gutenberg University Mainz |
since 2010 | Director of the Institute for Pathobiochemistry |